InMode Ltd. logo
InMode Ltd. INMD
$ 13.71 0.0%

Annual report 2025
added 04-04-2026

report update icon

InMode Ltd. EBITDA 2011-2026 | INMD

Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]

EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.

EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.

However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.

Annual EBITDA InMode Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
86.1 M 113 M 196 M 199 M 168 M 73.3 M 59.9 M 23.7 M 9.15 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
199 M 9.15 M 103 M

References

  1. Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.

EBITDA of other stocks in the Medical devices industry

Issuer EBITDA Price % 24h Market Cap Country
Bruker Corporation Bruker Corporation
BRKR
437 M $ 36.74 - $ 5.47 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
-23.4 M $ 9.38 - $ 266 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
-3.98 M - - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
-11.5 M - -26.83 % $ 2.62 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
-13.5 M $ 0.59 - $ 36.7 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
473 M $ 12.07 - $ 1.63 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-815 K - 3.58 % $ 2.21 M usaUSA
Delcath Systems Delcath Systems
DCTH
898 K $ 9.7 - $ 347 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-17.9 M $ 3.45 1.77 % $ 129 M franceFrance
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
-9.8 M - -5.86 % $ 30.6 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
1.42 B $ 81.19 - $ 47.5 B usaUSA
FONAR Corporation FONAR Corporation
FONR
9.84 M $ 18.6 - $ 122 M usaUSA
Globus Medical Globus Medical
GMED
757 M $ 88.6 - $ 12 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-30.2 M - - $ 475 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
-12.4 M $ 1.9 - $ 1.15 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
70.8 M $ 9.31 - $ 717 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
64.9 M $ 54.14 - $ 1.59 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-2.05 M $ 1.0 - $ 16.9 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
352 M $ 85.63 - $ 2.97 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
-18.1 M $ 15.94 - $ 374 M usaUSA
LENSAR LENSAR
LNSR
-21 M $ 5.89 -2.81 % $ 70.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
23.2 M - -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
-16.3 M - -20.74 % $ 369 K usaUSA
Medtronic PLC Medtronic PLC
MDT
8.82 B $ 86.28 - $ 111 B usaUSA
Align Technology Align Technology
ALGN
753 M $ 171.87 - $ 12.9 B usaUSA
Myomo Myomo
MYO
-13.5 M $ 0.7 - $ 29.3 M usaUSA
AxoGen AxoGen
AXGN
-1.19 M $ 32.64 - $ 1.5 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-53.2 M - - $ 3.31 B usaUSA
Orthofix Medical Orthofix Medical
OFIX
-4.11 M $ 11.77 - $ 466 M curacaoCuracao
Aziyo Biologics Aziyo Biologics
AZYO
-24.1 M - 1.37 % $ 20.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-14.1 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
88.4 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-8.53 M - 0.03 % $ 1.58 B israelIsrael
Penumbra Penumbra
PEN
207 M $ 329.87 - $ 12.8 B usaUSA
Misonix, Inc. Misonix, Inc.
MSON
-15.9 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
-31.1 M - - $ 111 M canadaCanada
Insulet Corporation Insulet Corporation
PODD
564 M $ 203.5 - $ 14.3 B usaUSA
Sintx Technologies Sintx Technologies
SINT
-10.4 M $ 2.53 0.4 % $ 7.02 M usaUSA
Butterfly Network Butterfly Network
BFLY
-65.5 M $ 4.13 -0.24 % $ 874 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
-64.8 M - - $ 955 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
1.16 B $ 32.63 - $ 23.8 B britainBritain
Stryker Corporation Stryker Corporation
SYK
6.46 B $ 332.3 - $ 127 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
35.9 M $ 24.57 - $ 562 M usaUSA
TELA Bio TELA Bio
TELA
-33.1 M $ 0.63 5.47 % $ 29.6 M usaUSA
TransMedics Group TransMedics Group
TMDX
136 M $ 104.8 - $ 3.56 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
26 M $ 19.17 - $ 1.3 B usaUSA
BIOLASE BIOLASE
BIOL
-15.1 M - -13.19 % $ 166 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
-67.6 M - 37.08 % $ 85.7 M usaUSA